{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T21:46:05Z","timestamp":1792014365043,"version":"4.4.0"},"reference-count":234,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100014717","name":"National Outstanding Youth Science Fund Project of National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["2023D01E12"],"award-info":[{"award-number":["2023D01E12"]}],"id":[{"id":"10.13039\/100014717","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010036","name":"China-Japan Friendship Hospital Youth Science and Technology Excellence Project","doi-asserted-by":"publisher","award":["2022TSYCCX0112"],"award-info":[{"award-number":["2022TSYCCX0112"]}],"id":[{"id":"10.13039\/501100010036","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018754","name":"Science and Technology Plan Projects of Tibet Autonomous Region","doi-asserted-by":"publisher","award":["2022E02061"],"award-info":[{"award-number":["2022E02061"]}],"id":[{"id":"10.13039\/501100018754","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011002","name":"National Natural Science Foundation of China-Yunnan Joint Fund","doi-asserted-by":"publisher","award":["82360394"],"award-info":[{"award-number":["82360394"]}],"id":[{"id":"10.13039\/501100011002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015360","name":"State Key Laboratory of Infectious Disease Prevention and Control","doi-asserted-by":"publisher","award":["SKL-HIDCA-2021-JH11"],"award-info":[{"award-number":["SKL-HIDCA-2021-JH11"]}],"id":[{"id":"10.13039\/501100015360","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.lfs.2024.122986","type":"journal-article","created":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T06:37:11Z","timestamp":1723617431000},"page":"122986","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["The development of a human Brucella mucosal vaccine: What should be considered?"],"prefix":"10.1016","volume":"355","author":[{"given":"Tingting","family":"Tian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuejie","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiyu","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengwei","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huidong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueyue","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianbing","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengbo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2024.122986_bb0005","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.1462-5822.2005.00502.x","article-title":"The sheathed flagellum of Brucella melitensis is involved in persistence in a murine model of infection","volume":"7","author":"Fretin","year":"2005","journal-title":"Cell. Microbiol."},{"issue":"1","key":"10.1016\/j.lfs.2024.122986_bb0010","first-page":"35","article-title":"Brucellosis \u2013 a worldwide zoonosis (in Polish)","volume":"89","author":"Mizak","year":"2014","journal-title":"\u017byc. Wet."},{"key":"10.1016\/j.lfs.2024.122986_bb0015","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2022.890252","article-title":"Co-delivery of doxycycline and hydroxychloroquine using CdTe-labeled solid lipid nanoparticles for treatment of acute and chronic brucellosis","volume":"10","author":"Hosseini","year":"2022","journal-title":"Front. Chem."},{"key":"10.1016\/j.lfs.2024.122986_bb0020","author":"Brucellosis"},{"key":"10.1016\/j.lfs.2024.122986_bb0025","author":"Al-Nassir"},{"key":"10.1016\/j.lfs.2024.122986_bb0030","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1128\/AEM.02928-14","article-title":"Glutamate decarboxylase-dependent acid resistance in Brucella spp.: distribution and contribution to fitness under extremely acidic conditions","volume":"81","author":"Damiano","year":"2015","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.lfs.2024.122986_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.meegid.2020.104635","article-title":"Genomic insights into Brucella","volume":"87","author":"Rajendhran","year":"2021","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.lfs.2024.122986_bb0040","unstructured":"EJ., Y. Brucella spp. Principles and Practice of Clinical Bacteriology, 2nd ed."},{"key":"10.1016\/j.lfs.2024.122986_bb0045","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1080\/01652176.2020.1868616","article-title":"Bovine brucellosis - a comprehensive review","volume":"41","author":"Khurana","year":"2021","journal-title":"Vet. Q."},{"key":"10.1016\/j.lfs.2024.122986_bb0050","first-page":"1","article-title":"Swine brucellosis: current perspectives","volume":"8","author":"Olsen","year":"2017","journal-title":"Vet. Med. (Auckl)"},{"key":"10.1016\/j.lfs.2024.122986_bb0055","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.cvsm.2023.05.002","article-title":"Update on Brucella canis: understanding the past and preparing for the future","volume":"53","author":"Sebzda","year":"2023","journal-title":"Vet. Clin. North Am. Small Anim. Pract."},{"key":"10.1016\/j.lfs.2024.122986_bb0060","doi-asserted-by":"crossref","first-page":"151","DOI":"10.21307\/pjm-2018-029","article-title":"Brucella - virulence factors, pathogenesis and treatment","volume":"67","author":"G\u0142owacka","year":"2018","journal-title":"Pol. J. Microbiol."},{"key":"10.1016\/j.lfs.2024.122986_bb0065","doi-asserted-by":"crossref","first-page":"2295398","DOI":"10.1080\/07853890.2023.2295398","article-title":"Brucellosis: epidemiology, pathogenesis, diagnosis and treatment-a comprehensive review","volume":"55","author":"Qureshi","year":"2023","journal-title":"Ann. Med."},{"key":"10.1016\/j.lfs.2024.122986_bb0070","doi-asserted-by":"crossref","first-page":"1136674","DOI":"10.3389\/fcimb.2023.1136674","article-title":"Research progress on complications of Brucellosis","volume":"13","author":"Jin","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.lfs.2024.122986_bb0075","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S1473-3099(07)70286-4","article-title":"Human brucellosis","volume":"7","author":"Franco","year":"2007","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.lfs.2024.122986_bb0080","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.vetmic.2009.06.021","article-title":"Brucellosis: a re-emerging zoonosis","volume":"140","author":"Seleem","year":"2010","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.lfs.2024.122986_bb0085","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2174\/1874318801004010119","article-title":"Clinical manifestations of brucellosis in domestic animals and humans","volume":"4","author":"Megid","year":"2010","journal-title":"Op. Vet. Sci. J."},{"key":"10.1016\/j.lfs.2024.122986_bb0090","doi-asserted-by":"crossref","first-page":"2290839","DOI":"10.1080\/22221751.2023.2290839","article-title":"Long ignored but making a comeback: a worldwide epidemiological evolution of human brucellosis","volume":"13","author":"Liu","year":"2024","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.lfs.2024.122986_bb0095","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1097\/QCO.0b013e3283638104","article-title":"Brucellosis in low-income and middle-income countries","volume":"26","author":"Rubach","year":"2013","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.lfs.2024.122986_bb0100","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.3201\/eid2909.230052","article-title":"Global estimate of human brucellosis incidence","volume":"29","author":"Laine","year":"2023","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.lfs.2024.122986_bb0105","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.cimid.2012.09.001","article-title":"A \u201cOne Health\u201d surveillance and control of brucellosis in developing countries: moving away from improvisation","volume":"36","author":"Godfroid","year":"2013","journal-title":"Comp. Immunol. Microbiol. Infect. Dis."},{"key":"10.1016\/j.lfs.2024.122986_bb0110","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.prevetmed.2011.04.007","article-title":"Brucellosis at the animal\/ecosystem\/human interface at the beginning of the 21st century","volume":"102","author":"Godfroid","year":"2011","journal-title":"Prev. Vet. Med."},{"key":"10.1016\/j.lfs.2024.122986_bb0115","unstructured":"Brucellosis.https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/brucellosis."},{"key":"10.1016\/j.lfs.2024.122986_bb0120","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1574-6976.2010.00211.x","article-title":"Towards a Brucella vaccine for humans","volume":"34","author":"Perkins","year":"2010","journal-title":"FEMS Microbiol. Rev."},{"key":"10.1016\/j.lfs.2024.122986_bb0125","first-page":"409","article-title":"Immunization with viable Brucella organisms. Results of a safety test in humans","volume":"26","author":"Spink","year":"1962","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.lfs.2024.122986_bb0130","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.cell.2020.09.040","article-title":"Why and how vaccines work","volume":"183","author":"Iwasaki","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.lfs.2024.122986_bb0135","article-title":"Immune response of inactivated rabies vaccine inoculated via intraperitoneal, intramuscular, subcutaneous and needle-free injection technology-based intradermal routes in mice","volume":"24","author":"Zhao","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2024.122986_bb0140","article-title":"Comparative immunogenicity analysis of intradermal versus intramuscular immunization with a recombinant human adenovirus type 5 vaccine against Ebola virus","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2024.122986_bb0145","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.752444","article-title":"Fast DNA vaccination strategy elicits a stronger immune response dependent on CD8(+)CD11c(+) cell accumulation","volume":"11","author":"Liu","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.lfs.2024.122986_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.122559","article-title":"Emerging adjuvants for intradermal vaccination","volume":"632","author":"Chen","year":"2023","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.lfs.2024.122986_bb0155","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1080\/17425247.2019.1568408","article-title":"Subcutaneous delivery of biotherapeutics: challenges at the injection site","volume":"16","author":"Sequeira","year":"2019","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.lfs.2024.122986_bb0160","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41541-019-0134-4","article-title":"Microprojection arrays applied to skin generate mechanical stress, induce an inflammatory transcriptome and cell death, and improve vaccine-induced immune responses","volume":"4","author":"Ng","year":"2019","journal-title":"NPJ Vacc."},{"key":"10.1016\/j.lfs.2024.122986_bb0165","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0140-6736(17)30575-5","article-title":"The safety, immunogenicity, and acceptability of inactivated influenza vaccine delivered by microneedle patch (TIV-MNP 2015): a randomised, partly blinded, placebo-controlled, phase 1 trial","volume":"390","author":"Rouphael","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.lfs.2024.122986_bb0170","doi-asserted-by":"crossref","DOI":"10.3390\/nano7060147","article-title":"ZnO nano-rod devices for intradermal delivery and immunization","volume":"7","author":"Nayak","year":"2017","journal-title":"Nanomaterials (Basel)"},{"key":"10.1016\/j.lfs.2024.122986_bb0175","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1002\/adhm.201300006","article-title":"Host responses in human skin after conventional intradermal injection or microneedle administration of virus-like-particle influenza vaccine","volume":"2","author":"Pearton","year":"2013","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.lfs.2024.122986_bb0180","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0002-9440(10)63097-0","article-title":"Antigen transport into Peyer\u2019s patches: increased uptake by constant numbers of M cells","volume":"164","author":"Gebert","year":"2004","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.lfs.2024.122986_bb0185","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/nri.2015.17","article-title":"Mucosal immunity to pathogenic intestinal bacteria","volume":"16","author":"Perez-Lopez","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.lfs.2024.122986_bb0190","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0168-3659(99)00231-X","article-title":"Oral vaccine delivery","volume":"65","author":"Russell-Jones","year":"2000","journal-title":"J. Control. Release"},{"key":"10.1016\/j.lfs.2024.122986_bb0195","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.819859","article-title":"Induction of mucosal IgA-mediated protective immunity against nontypeable Haemophilus influenzae infection by a cationic nanogel-based P6 nasal vaccine","volume":"13","author":"Nakahashi-Ouchida","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2024.122986_bb0200","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.744887","article-title":"The mucosal and serological immune responses to the novel coronavirus (SARS-CoV-2) vaccines","volume":"12","author":"Chan","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2024.122986_bb0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaci.2022.05.002","article-title":"The unfulfilled potential of mucosal immunization","volume":"150","author":"Baker","year":"2022","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.lfs.2024.122986_bb0210","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1080\/14760584.2023.2268724","article-title":"Mucosal vaccination: onward and upward","volume":"22","author":"Tsai","year":"2023","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.lfs.2024.122986_bb0215","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/s41577-021-00583-2","article-title":"Mucosal vaccines - fortifying the frontiers","volume":"22","author":"Lavelle","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.lfs.2024.122986_bb0220","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.647220","article-title":"Subunit vaccine ESAT-6:c-di-AMP delivered by intranasal route elicits immune responses and protects against mycobacterium tuberculosis infection","volume":"11","author":"Ning","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.lfs.2024.122986_bb0225","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1016\/j.vaccine.2011.01.090","article-title":"Efficacy of vaccination strategies against intranasal challenge with Brucella abortus in BALB\/c mice","volume":"29","author":"Surendran","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.lfs.2024.122986_bb0230","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/mi.2007.9","article-title":"Terminology: nomenclature of mucosa-associated lymphoid tissue","volume":"1","author":"Brandtzaeg","year":"2008","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.lfs.2024.122986_bb0235","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1053\/j.gastro.2005.03.047","article-title":"Human intestinal IgA response is generated in the organized gut-associated lymphoid tissue but not in the lamina propria","volume":"128","author":"Boursier","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.lfs.2024.122986_bb0240","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/imm.13526","article-title":"Vaccines, adjuvants and key factors for mucosal immune response","volume":"167","author":"Correa","year":"2022","journal-title":"Immunology"},{"key":"10.1016\/j.lfs.2024.122986_bb0245","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.it.2012.09.006","article-title":"Antigen sampling in the small intestine","volume":"34","author":"Schulz","year":"2013","journal-title":"Trends Immunol."},{"key":"10.1016\/j.lfs.2024.122986_bb0250","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.0105-2896.2005.00281.x","article-title":"Development of intestinal M cells","volume":"206","author":"Mach","year":"2005","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.lfs.2024.122986_bb0255","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1749-6632.2000.tb05240.x","article-title":"Role of M cells in intestinal barrier function","volume":"915","author":"Kucharzik","year":"2000","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.lfs.2024.122986_bb0260","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1053\/j.gastro.2004.01.028","article-title":"Gastrointestinal dendritic cells play a role in immunity, tolerance, and disease","volume":"127","author":"Bilsborough","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.lfs.2024.122986_bb0265","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1084\/jem.190.2.229","article-title":"Freshly isolated Peyer\u2019s patch, but not spleen, dendritic cells produce interleukin 10 and induce the differentiation of T helper type 2 cells","volume":"190","author":"Iwasaki","year":"1999","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.lfs.2024.122986_bb0270","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/tra.12707","article-title":"Intestinal M cells: tireless samplers of enteric microbiota","volume":"21","author":"Kanaya","year":"2020","journal-title":"Traffic"},{"key":"10.1016\/j.lfs.2024.122986_bb0275","doi-asserted-by":"crossref","first-page":"1018165","DOI":"10.3389\/fmicb.2022.1018165","article-title":"Activation of mucosal immunity as a novel therapeutic strategy for combating brucellosis","volume":"13","author":"Pascual","year":"2022","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.lfs.2024.122986_bb0280","doi-asserted-by":"crossref","first-page":"C1161","DOI":"10.1152\/ajpcell.00338.2022","article-title":"The multifunctional nature of CD103 (\u03b1E\u03b27 integrin) signaling in tissue-resident lymphocytes","volume":"323","author":"Xu","year":"2022","journal-title":"Am. J. Phys. Cell Physiol."},{"key":"10.1016\/j.lfs.2024.122986_bb0285","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.602122","article-title":"Lymphatic endothelial cell activation and dendritic cell transmigration is modified by genetic deletion of Clever-1","volume":"12","author":"Tadayon","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2024.122986_bb0290","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1600-065X.2006.00482.x","article-title":"Generation of gut-homing T cells and their localization to the small intestinal mucosa","volume":"215","author":"Johansson-Lindbom","year":"2007","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.lfs.2024.122986_bb0295","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/j.ajpath.2015.03.003","article-title":"Pathogenesis and immunobiology of brucellosis: review of Brucella-host interactions","volume":"185","author":"de Figueiredo","year":"2015","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.lfs.2024.122986_bb0300","doi-asserted-by":"crossref","DOI":"10.1128\/MMBR.00021-19","article-title":"Uncovering the hidden credentials of Brucella virulence","volume":"85","author":"Roop","year":"2021","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"10.1016\/j.lfs.2024.122986_bb0305","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.micpath.2011.07.006","article-title":"Transcriptional profile of the intracellular pathogen Brucella melitensis following HeLa cells infection","volume":"51","author":"Rossetti","year":"2011","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.lfs.2024.122986_bb0310","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.micinf.2012.03.003","article-title":"Transcriptome analysis of HeLa cells response to Brucella melitensis infection: a molecular approach to understand the role of the mucosal epithelium in the onset of the Brucella pathogenesis","volume":"14","author":"Rossetti","year":"2012","journal-title":"Microbes Infect."},{"key":"10.1016\/j.lfs.2024.122986_bb0315","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1080\/23744235.2019.1568545","article-title":"A review of the immunopathogenesis of Brucellosis","volume":"51","author":"Amjadi","year":"2019","journal-title":"Infect. Dis. (Lond.)"},{"key":"10.1016\/j.lfs.2024.122986_bb0320","doi-asserted-by":"crossref","first-page":"1129172","DOI":"10.3389\/fcimb.2023.1129172","article-title":"The mechanism of chronic intracellular infection with Brucella spp","volume":"13","author":"Guo","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.lfs.2024.122986_bb0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.mib.2024.102427","article-title":"The \u2018ins and outs\u2019 of Brucella intracellular journey","volume":"78","author":"Marchesini","year":"2024","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.lfs.2024.122986_bb0330","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1073\/pnas.0406873102","article-title":"Brucella coopts the small GTPase Sar1 for intracellular replication","volume":"102","author":"Celli","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.lfs.2024.122986_bb0335","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.chom.2017.07.017","article-title":"A Brucella type IV effector targets the COG tethering complex to remodel host secretory traffic and promote intracellular replication","volume":"22","author":"Miller","year":"2017","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.lfs.2024.122986_bb0340","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3389\/fcimb.2015.00072","article-title":"Type IV secretion system of Brucella spp. and its effectors","volume":"5","author":"Ke","year":"2015","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.lfs.2024.122986_bb0345","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0378-1135(02)00214-6","article-title":"Brucella intracellular life: from invasion to intracellular replication","volume":"90","author":"Gorvel","year":"2002","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.lfs.2024.122986_bb0350","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abp8632","article-title":"Regional specification of oral mucosal immunity","volume":"7","author":"Williams","year":"2022","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.lfs.2024.122986_bb0355","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.oooo.2013.07.013","article-title":"Oral mucosal immunity","volume":"116","author":"Feller","year":"2013","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."},{"key":"10.1016\/j.lfs.2024.122986_bb0360","article-title":"Cervical lymph nodes as a selective niche for Brucella during oral infections","volume":"10","author":"von Bargen","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2024.122986_bb0365","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/srep00495","article-title":"The pathophysiology of inhalational brucellosis in BALB\/c mice","volume":"2","author":"Henning","year":"2012","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2024.122986_bb0370","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens9050328","article-title":"The role of ST2 receptor in the regulation of Brucella abortus oral infection","volume":"9","author":"Santos","year":"2020","journal-title":"Pathogens"},{"key":"10.1016\/j.lfs.2024.122986_bb0375","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.3389\/fimmu.2019.01759","article-title":"Immune Response to Mucosal Brucella Infection","volume":"10","author":"L\u00f3pez-Santiago","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2024.122986_bb0380","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.actbio.2014.09.019","article-title":"Galactosylated liposome as a dendritic cell-targeted mucosal vaccine for inducing protective anti-tumor immunity","volume":"11","author":"Jiang","year":"2015","journal-title":"Acta Biomater."},{"key":"10.1016\/j.lfs.2024.122986_bb0385","doi-asserted-by":"crossref","first-page":"398","DOI":"10.2460\/ajvr.2001.62.398","article-title":"Bacteriologic and histologic features in mice after intranasal inoculation of Brucella melitensis","volume":"62","author":"Mense","year":"2001","journal-title":"Am. J. Vet. Res."},{"key":"10.1016\/j.lfs.2024.122986_bb0390","doi-asserted-by":"crossref","first-page":"3458","DOI":"10.1002\/eji.201040497","article-title":"Contrasting roles of macrophages and dendritic cells in controlling initial pulmonary Brucella infection","volume":"40","author":"Archambaud","year":"2010","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.lfs.2024.122986_bb0395","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.micinf.2009.01.010","article-title":"Smooth Brucella strains invade and replicate in human lung epithelial cells without inducing cell death","volume":"11","author":"Ferrero","year":"2009","journal-title":"Microbes Infect."},{"key":"10.1016\/j.lfs.2024.122986_bb0400","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.3389\/fimmu.2017.01011","article-title":"Btp proteins from Brucella abortus modulate the lung innate immune response to infection by the respiratory route","volume":"8","author":"Hielpos","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2024.122986_bb0405","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.micinf.2020.06.001","article-title":"Pathogenesis and immune response in Brucella infection acquired by the respiratory route","volume":"22","author":"Ferrero","year":"2020","journal-title":"Microbes Infect."},{"key":"10.1016\/j.lfs.2024.122986_bb0410","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nri3007","article-title":"The light and dark sides of intestinal intraepithelial lymphocytes","volume":"11","author":"Cheroutre","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.lfs.2024.122986_bb0415","doi-asserted-by":"crossref","first-page":"4197","DOI":"10.1128\/IAI.00417-09","article-title":"Establishment of systemic Brucella melitensis infection through the digestive tract requires urease, the type IV secretion system, and lipopolysaccharide O antigen","volume":"77","author":"Paix\u00e3o","year":"2009","journal-title":"Infect. Immun."},{"key":"10.1016\/j.lfs.2024.122986_bb0420","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.4049\/jimmunol.1103332","article-title":"Cutting Edge: Brucella abortus exploits a cellular prion protein on intestinal M cells as an invasive receptor","volume":"189","author":"Nakato","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.lfs.2024.122986_bb0425","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/cei.13285","article-title":"Mucosal vaccines and technology","volume":"196","author":"Miquel-Clop\u00e9s","year":"2019","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.lfs.2024.122986_bb0430","article-title":"The effects of secretory IgA in the mucosal immune system","volume":"2020","author":"Li","year":"2020","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.lfs.2024.122986_bb0435","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1016\/S0140-6736(12)60436-X","article-title":"Cholera","volume":"379","author":"Harris","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.lfs.2024.122986_bb0440","doi-asserted-by":"crossref","first-page":"7238","DOI":"10.1016\/j.vaccine.2012.10.002","article-title":"Live oral typhoid vaccine Salmonella Typhi Ty21a - a surrogate vaccine against non-typhoid salmonella?","volume":"30","author":"Kantele","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.lfs.2024.122986_bb0445","first-page":"247","article-title":"The Salmonella enterica serotype Typhi regulator TviA reduces interleukin-8 production in intestinal epithelial cells by repressing flagellin secretion","volume":"10","author":"Winter","year":"2008","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.lfs.2024.122986_bb0450","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1038\/nm1213","article-title":"Mucosal immunity and vaccines","volume":"11","author":"Holmgren","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.lfs.2024.122986_bb0455","article-title":"Oral vaccines: a better future of immunization","volume":"11","author":"Kwong","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.lfs.2024.122986_bb0460","first-page":"1641","article-title":"Protection by oral administration of brucella abortus strain 19 against an oral challenge exposure with a pathogenic strain of Brucella","volume":"44","author":"Nicoletti","year":"1983","journal-title":"Am. J. Vet. Res."},{"key":"10.1016\/j.lfs.2024.122986_bb0465","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0167-5877(96)01110-5","article-title":"A review of the use of B. Melitensis rev 1 vaccine in adult sheep and goats","volume":"31","author":"Blasco","year":"1997","journal-title":"Prev. Vet. Med."},{"key":"10.1016\/j.lfs.2024.122986_bb0470","first-page":"351","article-title":"Vaccination of ewes by a single conjunctival administration of Brucella melitensis Rev. 1 vaccine","volume":"16","author":"Fensterbank","year":"1985","journal-title":"Ann. Rech. Vet."},{"key":"10.1016\/j.lfs.2024.122986_bb0475","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.vaccine.2015.09.116","article-title":"Brucella suis strain 2 vaccine is safe and protective against heterologous Brucella spp. infections","volume":"34","author":"Zhu","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.lfs.2024.122986_bb0480","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/0264-410X(86)90131-3","article-title":"Orally administrable brucellosis vaccine: Brucella suis strain 2 vaccine","volume":"4","author":"Xin","year":"1986","journal-title":"Vaccine"},{"key":"10.1016\/j.lfs.2024.122986_bb0485","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/0264-410X(90)90247-J","article-title":"Brucella suis S2, brucella melitensis rev. 1 and Brucella abortus S19 living vaccines: residual virulence and immunity induced against three Brucella species challenge strains in mice","volume":"8","author":"Bosseray","year":"1990","journal-title":"Vaccine"},{"key":"10.1016\/j.lfs.2024.122986_bb0490","article-title":"Ag85a-S2 activates cGAS-STING signaling pathway in intestinal mucosal cells","volume":"10","author":"Dang","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.lfs.2024.122986_bb0495","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.2460\/ajvr.1998.59.12.1575","article-title":"Protection against infection and abortion induced by virulent challenge exposure after oral vaccination of cattle with Brucella abortus strain RB51","volume":"59","author":"Elzer","year":"1998","journal-title":"Am. J. Vet. Res."},{"key":"10.1016\/j.lfs.2024.122986_bb0500","first-page":"422","article-title":"Field-oriented trial of the Chinese Brucella suis strain 2 vaccine on sheep and goats in Libya","volume":"24","author":"Mustafa","year":"1993","journal-title":"Vet. Res."},{"key":"10.1016\/j.lfs.2024.122986_bb0505","doi-asserted-by":"crossref","first-page":"4165","DOI":"10.1128\/IAI.05080-11","article-title":"Protective live oral brucellosis vaccines stimulate Th1 and th17 cell responses","volume":"79","author":"Clapp","year":"2011","journal-title":"Infect. Immun."},{"key":"10.1016\/j.lfs.2024.122986_bb0510","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.995327","article-title":"Live mucosal vaccination stimulates potent protection via varied CD4(+) and CD8(+) T cell subsets against wild-type Brucella melitensis 16M challenge","volume":"13","author":"Goodwin","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2024.122986_bb0515","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.vaccine.2011.12.088","article-title":"Oral immunization of mice with recombinant Lactococcus lactis expressing Cu,Zn superoxide dismutase of Brucella abortus triggers protective immunity","volume":"30","author":"S\u00e1ez","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.lfs.2024.122986_bb0520","doi-asserted-by":"crossref","DOI":"10.1016\/j.cimid.2020.101470","article-title":"High protection of mice against Brucella abortus by oral immunization with recombinant probiotic Lactobacillus casei vector vaccine, expressing the outer membrane protein OMP19 of Brucella species","volume":"70","author":"Mohammadi","year":"2020","journal-title":"Comp. Immunol. Microbiol. Infect. Dis."},{"key":"10.1016\/j.lfs.2024.122986_bb0525","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1111\/cmi.12088","article-title":"Innate immune recognition of flagellin limits systemic persistence of Brucella","volume":"15","author":"Terwagne","year":"2013","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.lfs.2024.122986_bb0530","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.105829","article-title":"Evaluation of immunogenicity of novel multi-epitope subunit vaccines in combination with poly I:C against Brucella melitensis and Brucella abortus infection","volume":"75","author":"Sadeghi","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.lfs.2024.122986_bb0535","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jbiotec.2020.01.016","article-title":"Mannosylated chitosan nanoparticles loaded with FliC antigen as a novel vaccine candidate against Brucella melitensis and Brucella abortus infection","volume":"310","author":"Sadeghi","year":"2020","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.lfs.2024.122986_bb0540","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.imlet.2018.03.004","article-title":"Intraperitoneal immunization with Urease loaded N-trimethyl Chitosan nanoparticles elicits high protection against Brucella melitensis and Brucella abortus infections","volume":"199","author":"Abkar","year":"2018","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.lfs.2024.122986_bb0545","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.vetmic.2017.05.012","article-title":"Brucella lipopolysaccharide reinforced Salmonella delivering Brucella immunogens protects mice against virulent challenge","volume":"205","author":"Lalsiamthara","year":"2017","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.lfs.2024.122986_bb0550","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.jconrel.2012.07.030","article-title":"Conjunctival vaccination against Brucella ovis in mice with mannosylated nanoparticles","volume":"162","author":"Da Costa Martins","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.lfs.2024.122986_bb0555","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.vetimm.2019.02.005","article-title":"Mucosal immunization with polymeric antigen BLSOmp31 using alternative delivery systems against Brucella ovis in rams","volume":"209","author":"D\u00edaz","year":"2019","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.lfs.2024.122986_bb0560","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.micpath.2018.10.016","article-title":"Evaluation of DNA vaccine encoding BCSP(31) surface protein of Brucella abortus for protective immunity","volume":"125","author":"Imtiaz","year":"2018","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.lfs.2024.122986_bb0565","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijmm.2019.151362","article-title":"Elicitation of Th1\/Th2 related responses in mice by chitosan nanoparticles loaded with Brucella abortus malate dehydrogenase, outer membrane proteins 10 and 19","volume":"310","author":"Shim","year":"2020","journal-title":"Int. J. Med. Microbiol."},{"key":"10.1016\/j.lfs.2024.122986_bb0570","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.4049\/jimmunol.2300071","article-title":"A single nasal dose vaccination with a Brucella abortus mutant potently protects against pulmonary infection","volume":"210","author":"Wang","year":"2023","journal-title":"J. Immunol."},{"key":"10.1016\/j.lfs.2024.122986_bb0575","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s40249-021-00801-y","article-title":"A new candidate vaccine for human brucellosis based on influenza viral vectors: a preliminary investigation for the development of an immunization schedule in a guinea pig model","volume":"10","author":"Bugybayeva","year":"2021","journal-title":"Infect. Dis. Poverty"},{"key":"10.1016\/j.lfs.2024.122986_bb0580","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.vetmic.2018.11.022","article-title":"Intranasally administered anti-Brucella subunit vaccine formulation induces protective immune responses against nasal Brucella challenge","volume":"228","author":"Senevirathne","year":"2019","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.lfs.2024.122986_bb0585","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.3389\/fimmu.2019.01775","article-title":"The BtaF adhesin is necessary for full virulence during respiratory infection by Brucella suis and is a novel immunogen for nasal vaccination against Brucella infection","volume":"10","author":"Mu\u00f1oz Gonz\u00e1lez","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2024.122986_bb0590","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.121332","article-title":"Recent advancement, immune responses, and mechanism of action of various vaccines against intracellular bacterial infections","volume":"314","author":"Ali","year":"2023","journal-title":"Life Sci."},{"key":"10.1016\/j.lfs.2024.122986_bb0595","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1016\/j.vaccine.2018.02.069","article-title":"Safety implication of Salmonella based Brucella vaccine candidate in mice and in vitro human cell culture","volume":"36","author":"Lalsiamthara","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.lfs.2024.122986_bb0600","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1159\/000100515","article-title":"Vivotif--a 'magic shield' for protection against typhoid fever and delivery of heterologous antigens","volume":"53","author":"Gentschev","year":"2007","journal-title":"Chemotherapy"},{"key":"10.1016\/j.lfs.2024.122986_bb0605","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2022.925773","article-title":"Evaluation of Brucellosis vaccines: a comprehensive review","volume":"9","author":"Heidary","year":"2022","journal-title":"Front. Vet. Sci."},{"key":"10.1016\/j.lfs.2024.122986_bb0610","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0286358","article-title":"Design of multi-epitope vaccine candidate against Brucella type IV secretion system (T4SS)","volume":"18","author":"Yin","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2024.122986_bb0615","doi-asserted-by":"crossref","first-page":"10146","DOI":"10.1038\/s41598-022-14427-z","article-title":"Design of a multi-epitope vaccine candidate against Brucella melitensis","volume":"12","author":"Li","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2024.122986_bb0620","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1128\/CVI.00653-14","article-title":"Immunization with Brucella VirB proteins reduces organ colonization in mice through a Th1-type immune response and elicits a similar immune response in dogs","volume":"22","author":"Pollak","year":"2015","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.lfs.2024.122986_bb0625","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1007\/s11250-010-9621-3","article-title":"Comparative study on responses of cattle and water buffalo (Bubalus bubalis) to experimental inoculation of Brucella abortus biovar 1 by the intraconjunctival route--a preliminary report","volume":"42","author":"Adesiyun","year":"2010","journal-title":"Trop. Anim. Health Prod."},{"key":"10.1016\/j.lfs.2024.122986_bb0630","doi-asserted-by":"crossref","DOI":"10.3390\/v14020401","article-title":"mRNA vaccine development for emerging animal and zoonotic diseases","volume":"14","author":"Le","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.lfs.2024.122986_bb0635","doi-asserted-by":"crossref","first-page":"7278","DOI":"10.1038\/s41598-024-57793-6","article-title":"In silico designed novel multi-epitope mRNA vaccines against Brucella by targeting extracellular protein BtuB and LptD","volume":"14","author":"Shi","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2024.122986_bb0640","doi-asserted-by":"crossref","first-page":"2280377","DOI":"10.1080\/21505594.2023.2280377","article-title":"One-step preparation of a self-assembled bioconjugate nanovaccine against Brucella","volume":"14","author":"Huang","year":"2023","journal-title":"Virulence"},{"key":"10.1016\/j.lfs.2024.122986_bb0645","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24032700","article-title":"A comprehensive review of mRNA vaccines","volume":"24","author":"Gote","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2024.122986_bb0650","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6528\/ac3f54","article-title":"Nanoscale self-assembly: concepts, applications and challenges","volume":"33","author":"Amadi","year":"2022","journal-title":"Nanotechnology"},{"key":"10.1016\/j.lfs.2024.122986_bb0655","doi-asserted-by":"crossref","first-page":"3512","DOI":"10.1038\/s41598-019-40084-w","article-title":"The immunogenicity of OMP31 peptides and its protection against Brucella melitensis infection in mice","volume":"9","author":"Zhang","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2024.122986_bb0660","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1084\/jem.20111171","article-title":"Synthetic double-stranded RNA induces innate immune responses similar to a live viral vaccine in humans","volume":"208","author":"Caskey","year":"2011","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.lfs.2024.122986_bb0665","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/cmi.2017.167","article-title":"Lymphatic endothelial cells regulate B-cell homing to lymph nodes via a NIK-dependent mechanism","volume":"16","author":"Yang","year":"2019","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.lfs.2024.122986_bb0670","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1038\/ncomms3990","article-title":"Transcription factor IRF4 drives dendritic cells to promote Th2 differentiation","volume":"4","author":"Williams","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.lfs.2024.122986_bb0675","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1084\/jem.20111644","article-title":"Serum from patients with SLE instructs monocytes to promote IgG and IgA plasmablast differentiation","volume":"209","author":"Joo","year":"2012","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.lfs.2024.122986_bb0680","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/s41423-021-00809-2","article-title":"Safety, immunogenicity, and protection provided by unadjuvanted and adjuvanted formulations of a recombinant plant-derived virus-like particle vaccine candidate for COVID-19 in nonhuman primates","volume":"19","author":"Pillet","year":"2022","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.lfs.2024.122986_bb0685","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.3390\/toxins2071774","article-title":"Cholera-like enterotoxins and Regulatory T cells","volume":"2","author":"Basset","year":"2010","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.lfs.2024.122986_bb0690","doi-asserted-by":"crossref","first-page":"410","DOI":"10.4161\/hv.27147","article-title":"TLR7 and 9 agonists are highly effective mucosal adjuvants for norovirus virus-like particle vaccines","volume":"10","author":"Hjelm","year":"2014","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.lfs.2024.122986_bb0695","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.micinf.2008.07.005","article-title":"The role of innate immune receptors in the control of Brucella abortus infection: toll-like receptors and beyond","volume":"10","author":"Oliveira","year":"2008","journal-title":"Microbes Infect."},{"key":"10.1016\/j.lfs.2024.122986_bb0700","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1128\/IAI.72.1.176-186.2004","article-title":"Role of Toll-like receptor 4 in induction of cell-mediated immunity and resistance to Brucella abortus infection in mice","volume":"72","author":"Campos","year":"2004","journal-title":"Infect. Immun."},{"key":"10.1016\/j.lfs.2024.122986_bb0705","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1189\/jlb.4A0815-346R","article-title":"TLR9 is required for MAPK\/NF-\u03baB activation but does not cooperate with TLR2 or TLR6 to induce host resistance to Brucella abortus","volume":"99","author":"Gomes","year":"2016","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.lfs.2024.122986_bb0710","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s13770-021-00373-w","article-title":"Mucosal vaccine delivery using mucoadhesive polymer particulate systems","volume":"18","author":"Cho","year":"2021","journal-title":"Tissue Eng. Regen. Med."},{"key":"10.1016\/j.lfs.2024.122986_bb0715","article-title":"Hemagglutinin nanoparticulate vaccine with controlled photochemical immunomodulation for pathogenic influenza-specific immunity","volume":"8","author":"Jeong","year":"2021","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.lfs.2024.122986_bb0720","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13081196","article-title":"Preparation of poly-lactic-co-glycolic acid nanoparticles in a dry powder formulation for pulmonary antigen delivery","volume":"13","author":"Scherlie\u00df","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.lfs.2024.122986_bb0725","doi-asserted-by":"crossref","DOI":"10.1016\/j.coviro.2023.101330","article-title":"Deimmunization of flagellin adjuvant for clinical application","volume":"60","author":"Rhee","year":"2023","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.lfs.2024.122986_bb0730","doi-asserted-by":"crossref","DOI":"10.1038\/emm.2017.172","article-title":"Bacterial flagellin-a potent immunomodulatory agent","volume":"49","author":"Hajam","year":"2017","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.lfs.2024.122986_bb0735","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1080\/14787210.2017.1254042","article-title":"Treatment of pulmonary brucellosis: a systematic review","volume":"15","author":"Solera","year":"2017","journal-title":"Expert Rev. Anti-Infect. Ther."},{"key":"10.1016\/j.lfs.2024.122986_bb0740","doi-asserted-by":"crossref","first-page":"431","DOI":"10.3389\/fimmu.2018.00431","article-title":"Lipid-based particles: versatile delivery systems for mucosal vaccination against infection","volume":"9","author":"Corth\u00e9sy","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2024.122986_bb0745","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/s41423-022-00897-8","article-title":"Virus-like particle vaccinology, from bench to bedside","volume":"19","author":"Mohsen","year":"2022","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.lfs.2024.122986_bb0750","doi-asserted-by":"crossref","first-page":"1188431","DOI":"10.3389\/fimmu.2023.1188431","article-title":"Immune responses in healthy adults elicited by a bivalent norovirus vaccine candidate composed of GI.4 and GII.4 VLPs without adjuvant","volume":"14","author":"Waerlop","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2024.122986_bb0755","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.arcmed.2023.02.003","article-title":"Protein-based nanoparticle vaccine approaches against infectious diseases","volume":"54","author":"Tapia","year":"2023","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.lfs.2024.122986_bb0760","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.xphs.2022.12.025","article-title":"Multi-epitope vaccine candidates associated with mannosylated chitosan and LPS conjugated chitosan nanoparticles against Brucella infection","volume":"112","author":"Sadeghi","year":"2023","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.lfs.2024.122986_bb0765","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s13346-023-01431-7","article-title":"Nanotechnology of inhalable vaccines for enhancing mucosal immunity","volume":"14","author":"Qin","year":"2024","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.lfs.2024.122986_bb0770","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12951-023-01782-w","article-title":"Aluminum-based metal-organic framework nanoparticles as pulmonary vaccine adjuvants","volume":"21","author":"Stillman","year":"2023","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.lfs.2024.122986_bb0775","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0059822","article-title":"The mucosal adjuvant cholera toxin B instructs non-mucosal dendritic cells to promote IgA production via retinoic acid and TGF-\u03b2","volume":"8","author":"Gloudemans","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2024.122986_bb0780","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.imlet.2004.11.009","article-title":"Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA","volume":"97","author":"Holmgren","year":"2005","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.lfs.2024.122986_bb0785","article-title":"A CTB-SARS-CoV-2-ACE-2 RBD mucosal vaccine protects against coronavirus infection","volume":"11","author":"D\u00e9nes","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.lfs.2024.122986_bb0790","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0224073","article-title":"Evaluation of the reactogenicity, adjuvanticity and antigenicity of LT(R192G) and LT(R192G\/L211A) by intradermal immunization in mice","volume":"14","author":"Maciel","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2024.122986_bb0795","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/j.vaccine.2009.10.147","article-title":"Toward the development of a stable, freeze-dried formulation of Helicobacter pylori killed whole cell vaccine adjuvanted with a novel mutant of Escherichia coli heat-labile toxin","volume":"28","author":"Summerton","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.lfs.2024.122986_bb0800","article-title":"Production and purification of LTB-RBD: a potential antigen for mucosal vaccine development against SARS-CoV-2","volume":"10","author":"Solis-Andrade","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.lfs.2024.122986_bb0805","article-title":"Evaluation of immunogenicity and efficacy of Fasciola hepatica Tetraspanin 2 (TSP2) fused to E. coli heat-labile enterotoxin B subunit LTB adjuvant following intranasal vaccination of cattle","volume":"9","author":"Zerna","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.lfs.2024.122986_bb0810","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00215-18","article-title":"The mucosal vaccine adjuvant LT(R192G\/L211A) or dmLT","volume":"3","author":"Clements","year":"2018","journal-title":"mSphere"},{"key":"10.1016\/j.lfs.2024.122986_bb0815","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.577823","article-title":"MPL adjuvant contains competitive antagonists of human TLR4","volume":"11","author":"Wang","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2024.122986_bb0820","series-title":"Committee for Medicinal Products for Human Use - Fendrix: EPAR - Scientific Discussion","author":"European Medicines Agency","year":"2005"},{"key":"10.1016\/j.lfs.2024.122986_bb0825","series-title":"Committee for Medicinal Products for Human Use - Cervarix: EPAR - Procedural Steps Taken Before Authorisation","author":"European Medicines Agency","year":"2007"},{"key":"10.1016\/j.lfs.2024.122986_bb0830","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.2147\/IJN.S30197","article-title":"Structure-dependent immunostimulatory effect of CpG oligodeoxynucleotides and their delivery system","volume":"7","author":"Hanagata","year":"2012","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.lfs.2024.122986_bb0835","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ijpharm.2017.11.009","article-title":"Oral hepatitis B vaccine: chitosan or glucan based delivery systems for efficient HBsAg immunization following subcutaneous priming","volume":"535","author":"Soares","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.lfs.2024.122986_bb0840","doi-asserted-by":"crossref","first-page":"5145","DOI":"10.1016\/j.vaccine.2011.05.041","article-title":"Safety and immunogenicity of a recombinant M2e-flagellin influenza vaccine (STF2.4xM2e) in healthy adults","volume":"29","author":"Turley","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.lfs.2024.122986_bb0845","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.ijbiomac.2022.09.180","article-title":"A SARS-CoV-2 vaccine based on conjugation of SARS-CoV-2 RBD with IC28 peptide and mannan","volume":"222","author":"He","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.lfs.2024.122986_bb0850","doi-asserted-by":"crossref","first-page":"4331","DOI":"10.1016\/j.vaccine.2018.05.090","article-title":"Fibroblast-stimulating lipopeptide-1 as a potential mucosal adjuvant enhances mucosal and systemic immune responses to enterovirus 71 vaccine","volume":"36","author":"Lin","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.lfs.2024.122986_bb0855","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.micinf.2019.02.005","article-title":"Pam3CSK4 adjuvant given intranasally boosts anti-Leishmania immunogenicity but not protective immune responses conferred by LaAg vaccine against visceral leishmaniasis","volume":"21","author":"Salgado","year":"2019","journal-title":"Microbes Infect."},{"key":"10.1016\/j.lfs.2024.122986_bb0860","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0061287","article-title":"Evaluation of an intranasal virosomal vaccine against respiratory syncytial virus in mice: effect of TLR2 and NOD2 ligands on induction of systemic and mucosal immune responses","volume":"8","author":"Shafique","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2024.122986_bb0865","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2013730118","article-title":"Synthetic protein conjugate vaccines provide protection against Mycobacterium tuberculosis in mice","volume":"118","author":"Hanna","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.lfs.2024.122986_bb0870","article-title":"Surface immunogenic protein of streptococcus group B is an agonist of toll-like receptors 2 and 4 and a potential immune adjuvant","volume":"8","author":"Diaz-Dinamarca","year":"2020","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.lfs.2024.122986_bb0875","doi-asserted-by":"crossref","first-page":"4191","DOI":"10.1007\/s12274-021-4012-9","article-title":"A chitosan-mediated inhalable nanovaccine against SARS-CoV-2","volume":"15","author":"Zhuo","year":"2022","journal-title":"Nano Res."},{"key":"10.1016\/j.lfs.2024.122986_bb0880","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1080\/21691401.2018.1438450","article-title":"Cationic DDA\/TDB liposome as a mucosal vaccine adjuvant for uptake by dendritic cells in vitro induces potent humoural immunity","volume":"46","author":"Qu","year":"2018","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"10.1016\/j.lfs.2024.122986_bb0885","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1208\/s12249-022-02425-3","article-title":"Enhanced influenza immunity by nasal mucosal administration of the TPGS-modified liposomal vaccine","volume":"23","author":"Ma","year":"2022","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.lfs.2024.122986_bb0890","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ijpharm.2017.09.011","article-title":"Novel freeze-dried DDA and TPGS liposomes are suitable for nasal delivery of vaccine","volume":"533","author":"Yusuf","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.lfs.2024.122986_bb0895","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jconrel.2022.09.031","article-title":"Polyethylene glycol (PEG): the nature, immunogenicity, and role in the hypersensitivity of PEGylated products","volume":"351","author":"Ibrahim","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.lfs.2024.122986_bb0900","doi-asserted-by":"crossref","first-page":"7098","DOI":"10.1016\/j.vaccine.2014.10.036","article-title":"A novel liposomal adjuvant system, CAF01, promotes long-lived Mycobacterium tuberculosis-specific T-cell responses in human","volume":"32","author":"van Dissel","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.lfs.2024.122986_bb0905","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/mi.2016.28","article-title":"Vaccine-induced Th17 cells are established as resident memory cells in the lung and promote local IgA responses","volume":"10","author":"Christensen","year":"2017","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.lfs.2024.122986_bb0910","doi-asserted-by":"crossref","DOI":"10.1126\/science.aau0810","article-title":"Pulmonary surfactant-biomimetic nanoparticles potentiate heterosubtypic influenza immunity","volume":"367","author":"Wang","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.lfs.2024.122986_bb0915","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.3389\/fimmu.2019.02274","article-title":"Enhancing immune response and heterosubtypic protection ability of inactivated H7N9 vaccine by using STING agonist as a mucosal adjuvant","volume":"10","author":"Luo","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2024.122986_bb0920","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jconrel.2021.11.002","article-title":"A respirable HPV-L2 dry-powder vaccine with GLA as amphiphilic lubricant and immune-adjuvant","volume":"340","author":"Rossi","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.lfs.2024.122986_bb0925","doi-asserted-by":"crossref","first-page":"4203","DOI":"10.1007\/s10904-020-01572-z","article-title":"Aluminum nanoparticles acting as a pulmonary Vaccine Adjuvant-Delivery System (VADS) able to safely elicit robust systemic and mucosal immunity","volume":"30","author":"Wang","year":"2020","journal-title":"J. Inorg. Organomet. Polym. Mater."},{"key":"10.1016\/j.lfs.2024.122986_bb0930","doi-asserted-by":"crossref","first-page":"13582","DOI":"10.1038\/s41598-018-31995-1","article-title":"Quillaja brasiliensis saponin-based nanoparticulate adjuvants are capable of triggering early immune responses","volume":"8","author":"Cibulski","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2024.122986_bb0935","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1002\/eji.201041297","article-title":"CD4+ T-cell immunity in the female genital tract is critically dependent on local mucosal immunization","volume":"41","author":"Marks","year":"2011","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.lfs.2024.122986_bb0940","doi-asserted-by":"crossref","first-page":"50592","DOI":"10.1021\/acsami.2c15644","article-title":"Universal and translational nanoparticulate CpG adjuvant","volume":"14","author":"Qiao","year":"2022","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.lfs.2024.122986_bb0945","doi-asserted-by":"crossref","first-page":"50","DOI":"10.7774\/cevr.2012.1.1.50","article-title":"Mucosal vaccine adjuvants update","volume":"1","author":"Rhee","year":"2012","journal-title":"Clin. Exp. Vacc. Res."},{"key":"10.1016\/j.lfs.2024.122986_bb0950","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/546596","article-title":"Mechanisms of innate lymphoid cell and natural killer T cell activation during mucosal inflammation","volume":"2014","author":"Nau","year":"2014","journal-title":"J Immunol Res"},{"key":"10.1016\/j.lfs.2024.122986_bb0955","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1038\/s41423-021-00689-6","article-title":"Dynamic regulation of innate lymphoid cells in the mucosal immune system","volume":"18","author":"Shao","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.lfs.2024.122986_bb0960","doi-asserted-by":"crossref","first-page":"1146077","DOI":"10.3389\/fimmu.2023.1146077","article-title":"Transcriptional control of ILC identity","volume":"14","author":"Korchagina","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2024.122986_bb0965","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1146\/annurev-immunol-101819-025146","article-title":"Dendritic cell regulation of T helper cells","volume":"39","author":"Yin","year":"2021","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.lfs.2024.122986_bb0970","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006373","article-title":"Compartment-specific distribution of human intestinal innate lymphoid cells is altered in HIV patients under effective therapy","volume":"13","author":"Kr\u00e4mer","year":"2017","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.lfs.2024.122986_bb0975","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2016.07.043","article-title":"Human lung natural killer cells are predominantly comprised of highly differentiated hypofunctional CD69(\u2212)CD56(dim) cells","volume":"139","author":"Marquardt","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.lfs.2024.122986_bb0980","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0145961","article-title":"Characterization and quantification of innate lymphoid cell subsets in human lung","volume":"11","author":"De Grove","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2024.122986_bb0985","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1038\/s41467-019-09883-7","article-title":"IL-1\u03b2, IL-23, and TGF-\u03b2 drive plasticity of human ILC2s towards IL-17-producing ILCs in nasal inflammation","volume":"10","author":"Golebski","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.lfs.2024.122986_bb0990","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.immuni.2017.02.019","article-title":"Dendritic cells display subset and tissue-specific maturation dynamics over human life","volume":"46","author":"Granot","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.lfs.2024.122986_bb0995","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.smim.2003.08.005","article-title":"Targeting T cell responses by selective chemokine receptor expression","volume":"15","author":"Campbell","year":"2003","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.lfs.2024.122986_bb1000","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/mi.2007.14","article-title":"Differentiation and homing of IgA-secreting cells","volume":"1","author":"Mora","year":"2008","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.lfs.2024.122986_bb1005","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19020485","article-title":"Integrins in T cell physiology","volume":"19","author":"Bertoni","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2024.122986_bb1010","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/JLB.4MR0120-208R","article-title":"Integrin \u03b14\u03b27 in HIV-1 infection: a critical review","volume":"108","author":"Liu","year":"2020","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.lfs.2024.122986_bb1015","doi-asserted-by":"crossref","first-page":"4134","DOI":"10.1016\/j.vaccine.2018.04.083","article-title":"Retinoic acid elicits a coordinated expression of gut homing markers on T lymphocytes of Zambian men receiving oral Vivotif, but not Rotarix, Dukoral or OPVERO vaccines","volume":"36","author":"Mwanza-Lisulo","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.lfs.2024.122986_bb1020","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/eji.201343340","article-title":"Vitamin A metabolism and mucosal immune function are distinct between BALB\/c and C57BL\/6 mice","volume":"45","author":"Goverse","year":"2015","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.lfs.2024.122986_bb1025","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1021\/acs.bioconjchem.7b00738","article-title":"Targeted strategies for mucosal vaccination","volume":"29","author":"Longet","year":"2018","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.lfs.2024.122986_bb1030","doi-asserted-by":"crossref","first-page":"3544","DOI":"10.4161\/hv.36174","article-title":"Roles of M cells in infection and mucosal vaccines","volume":"10","author":"Wang","year":"2014","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.lfs.2024.122986_bb1035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1001147","article-title":"Enhancing oral vaccine potency by targeting intestinal M cells","volume":"6","author":"Azizi","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.lfs.2024.122986_bb1040","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/nri1777","article-title":"Mucosal vaccines: the promise and the challenge","volume":"6","author":"Neutra","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.lfs.2024.122986_bb1045","doi-asserted-by":"crossref","DOI":"10.1038\/emm.2013.165","article-title":"Antigen targeting to M cells for enhancing the efficacy of mucosal vaccines","volume":"46","author":"Kim","year":"2014","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.lfs.2024.122986_bb1050","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1084\/jem.20070607","article-title":"A novel M cell-specific carbohydrate-targeted mucosal vaccine effectively induces antigen-specific immune responses","volume":"204","author":"Nochi","year":"2007","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.lfs.2024.122986_bb1055","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1002\/eji.201141592","article-title":"M cells expressing the complement C5a receptor are efficient targets for mucosal vaccine delivery","volume":"41","author":"Kim","year":"2011","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.lfs.2024.122986_bb1060","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3109\/1061186X.2011.611516","article-title":"Microfold-cell targeted surface engineered polymeric nanoparticles for oral immunization","volume":"20","author":"Malik","year":"2012","journal-title":"J. Drug Target."},{"key":"10.1016\/j.lfs.2024.122986_bb1065","doi-asserted-by":"crossref","first-page":"5187","DOI":"10.4049\/jimmunol.180.8.5187","article-title":"Low-dose tolerance is mediated by the microfold cell ligand, reovirus protein sigma1","volume":"180","author":"Rynda","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.lfs.2024.122986_bb1070","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/nri3727","article-title":"Dendritic cell-targeted vaccines--hope or hype?","volume":"14","author":"Kastenm\u00fcller","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.lfs.2024.122986_bb1075","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11061673","article-title":"Research progress of dendritic cell surface receptors and targeting","volume":"11","author":"Tong","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.lfs.2024.122986_bb1080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12223-019-00691-6","article-title":"Dendritic cells and Brucella spp. interaction: the sentinel host and the stealthy pathogen","volume":"65","author":"Avila-Calder\u00f3n","year":"2020","journal-title":"Folia Microbiol. (Praha)"},{"key":"10.1016\/j.lfs.2024.122986_bb1085","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/j.micinf.2008.07.035","article-title":"Brucella lipoproteins mimic dendritic cell maturation induced by Brucella abortus","volume":"10","author":"Zwerdling","year":"2008","journal-title":"Microbes Infect."},{"key":"10.1016\/j.lfs.2024.122986_bb1090","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.4049\/jimmunol.139.5.1609","article-title":"Targeted antigen presentation using crosslinked antibody heteroaggregates","volume":"139","author":"Snider","year":"1987","journal-title":"J. Immunol."},{"key":"10.1016\/j.lfs.2024.122986_bb1095","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2023.101762","article-title":"Targeting dendritic cells to advance cross-presentation and vaccination outcomes","volume":"68","author":"Macri","year":"2023","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.lfs.2024.122986_bb1100","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.949779","article-title":"Refining the DC-targeting vaccination for preventing emerging infectious diseases","volume":"13","author":"Pastor","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2024.122986_bb1105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0055143","article-title":"Colonic immune stimulation by targeted oral vaccine","volume":"8","author":"Kathania","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2024.122986_bb1110","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s12250-020-00199-1","article-title":"Chimeric Newcastle disease virus-like particles containing DC-binding peptide-fused Haemagglutinin protect chickens from virulent Newcastle disease virus and H9N2 avian influenza virus challenge","volume":"35","author":"Xu","year":"2020","journal-title":"Virol. Sin."},{"key":"10.1016\/j.lfs.2024.122986_bb1115","doi-asserted-by":"crossref","DOI":"10.1016\/j.vetmic.2020.108906","article-title":"Construction and evaluation of recombinant Lactobacillus plantarum NC8 delivering one single or two copies of G protein fused with a DC-targeting peptide (DCpep) as novel oral rabies vaccine","volume":"251","author":"Wang","year":"2020","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.lfs.2024.122986_bb1120","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.114021","article-title":"Oral nanomedicine for modulating immunity, intestinal barrier functions, and gut microbiome","volume":"179","author":"Lee","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.lfs.2024.122986_bb1125","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1080\/17474124.2017.1343143","article-title":"The intestinal barrier: a fundamental role in health and disease","volume":"11","author":"Vancamelbeke","year":"2017","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.lfs.2024.122986_bb1130","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1007\/s10068-019-00691-9","article-title":"Bacillus strains as human probiotics: characterization, safety, microbiome, and probiotic carrier","volume":"28","author":"Lee","year":"2019","journal-title":"Food Sci. Biotechnol."},{"key":"10.1016\/j.lfs.2024.122986_bb1135","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1177\/00220345231164111","article-title":"Mucoadhesive vaccine delivery systems for the oral mucosa","volume":"102","author":"Mokabari","year":"2023","journal-title":"J. Dent. Res."},{"key":"10.1016\/j.lfs.2024.122986_bb1140","doi-asserted-by":"crossref","first-page":"288","DOI":"10.18433\/J3NC79","article-title":"Intranasal drug delivery: how, why and what for?","volume":"12","author":"Pires","year":"2009","journal-title":"J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.lfs.2024.122986_bb1145","article-title":"Characterizing regional drug delivery within the nasal airways","volume":"1-15","author":"Chen","year":"2024","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.lfs.2024.122986_bb1150","doi-asserted-by":"crossref","first-page":"20825","DOI":"10.1021\/acsnano.3c05853","article-title":"Size-dependent in vivo transport of nanoparticles: implications for delivery, targeting, and clearance","volume":"17","author":"Xu","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.lfs.2024.122986_bb1155","first-page":"328","article-title":"Factors affecting nasal drug delivery and design strategies for intranasal drug delivery","volume":"52","author":"Hu","year":"2023","journal-title":"Zhejiang Da Xue Xue Bao Yi Xue Ban"},{"key":"10.1016\/j.lfs.2024.122986_bb1160","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ijbiomac.2017.10.101","article-title":"Chitosan-based particulate systems for the delivery of mucosal vaccines against infectious diseases","volume":"110","author":"Singh","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.lfs.2024.122986_bb1165","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1016\/j.vaccine.2014.04.019","article-title":"Vaccine preventable disease incidence as a complement to vaccine efficacy for setting vaccine policy","volume":"32","author":"Gessner","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.lfs.2024.122986_bb1170","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.imlet.2019.10.013","article-title":"Mucosal vaccines: strategies and challenges","volume":"217","author":"Li","year":"2020","journal-title":"Immunol. Lett."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320524005769?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320524005769?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T18:45:49Z","timestamp":1725648349000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320524005769"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":234,"alternative-id":["S0024320524005769"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2024.122986","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The development of a human Brucella mucosal vaccine: What should be considered?","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2024.122986","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"122986"}}